Cite

HARVARD Citation

    Nakamura, Y. et al. (2017). Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction. Journal of medical virology. 89 (4), pp. 665-671. [Online]. 
  
Back to record